Eli Lilly and Company: all 2,262 studies
Page 17 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)CompletedNCT06524830Phase 2
- A Study of Subcutaneous Injection in Healthy ParticipantsCompletedNCT06516913Not applicable
- A Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy ParticipantsCompletedNCT06503679Phase 1
- A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following RadiotherapyActive, not recruitingNCT06413706Phase 2
- A First-In-Human Study of LY3985297 in Healthy ParticipantsCompletedNCT06395012Phase 1
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)Active, not recruitingNCT06383390Phase 3
- A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With ObesityCompletedNCT06373146Phase 2
- A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes MellitusCompletedNCT06362265Phase 1
- Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)CompletedNCT06354660Phase 3
- A Study to Assess LY4100511 (DC-853) in Healthy Adult ParticipantsCompletedNCT06345794Phase 1
- A Study of LY3841136 in Overweight and Obese ParticipantsCompletedNCT06345066Phase 1
- A Study of Carbon-14-Labelled [14C] LY3473329 in Healthy Male ParticipantsCompletedNCT06342596Phase 1
- A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)Active, not recruitingNCT06339008Phase 3
- A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943CompletedNCT06313528Phase 1
- A Study to Evaluate Safety, Tolerability of LY4100511 (DC-853) in Healthy Asian and Non-Asian ParticipantsCompletedNCT06311656Phase 1
- A Study of LY3841136 in Japanese Participants With Obesity or OverweightCompletedNCT06297616Phase 1
- Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)Active, not recruitingNCT06297603Phase 3
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)Active, not recruitingNCT06292013Phase 3
- A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)CompletedNCT06280703Phase 1
- Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)Active, not recruitingNCT06260722Phase 3
- A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid TumorsActive, not recruitingNCT06238479Phase 1
- A Study of LY3537982 in Chinese Participants With Advanced Solid TumorsCompletedNCT06235983Phase 1
- [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT06229366Phase 1
- A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy ParticipantsCompletedNCT06194500Phase 1
- A Study Comparing Different Formulations of LY3410738 in Healthy Adult ParticipantsCompletedNCT06181084Phase 1
- A Study of LY3410738 in Healthy Adult ParticipantsCompletedNCT06181045Phase 1
- A Relative Bioavailability Study of LY3454738 in Healthy ParticipantsCompletedNCT06173895Phase 1
- A Multiple Dose Study of LY3209590 in Participants With Type 2 DiabetesCompletedNCT06169982Phase 1
- A First-In-Human Study of LY3839840 in Healthy ParticipantsCompletedNCT06153355Phase 1
- A Study of LY3971297 in Healthy ParticipantsCompletedNCT06148272Phase 1
- A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes MellitusCompletedNCT06132126Phase 1
- A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy ParticipantsCompletedNCT06111521Phase 1
- A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple SclerosisWithdrawnNCT06104683Phase 2
- A Study of [14C]-LOXO-783 in Healthy Adult ParticipantsCompletedNCT06102512Phase 1
- A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesActive, not recruitingNCT06075667Phase 3
- A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male ParticipantsCompletedNCT06052462Phase 1
- A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male ParticipantsCompletedNCT06049108Phase 1
- A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesCompletedNCT06047548Phase 3
- A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis SuppurativaCompletedNCT06046729Phase 2
- Mass Balance and Pharmacokinetics (PK) of [14C]-DC-806 in Healthy Male ParticipantsCompletedNCT06045000Phase 1
- A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or ObeseCompletedNCT06039826Phase 1
- A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and ObesityActive, not recruitingNCT06037252Phase 2
- A Study to Evaluate the Effect of Food on LOXO-783 in Healthy ParticipantsCompletedNCT06028425Phase 1
- A Single and Multiple Ascending Dose Study of LY3876602 in Healthy ParticipantsCompletedNCT06007638Phase 1
- A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection DevicesCompletedNCT06003465Phase 1
- Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial TreatmentTerminatedNCT05999968Phase 1
- A Study of LY3871801 in Healthy Asian and Non-Asian ParticipantsCompletedNCT05960851Phase 1
- A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy ParticipantsCompletedNCT05959109Phase 1
- A Study of LY3437943 in Healthy Participants With a High Body Mass IndexCompletedNCT05959096Phase 1
- A Study to Compare Two Formulations of LY3819469 in Healthy ParticipantsCompletedNCT05932446Phase 1
- A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the KneeCompletedNCT05931367Phase 3
- A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or OverweightCompletedNCT05929079Phase 3
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or OverweightCompletedNCT05929066Phase 3
- A Study of LY3437943 in Participants With Impaired and Normal Liver FunctionCompletedNCT05916560Phase 1
- A Study to Compare Two Formulations of LY3209590 in Healthy ParticipantsCompletedNCT05914688Phase 1
- A Study of [14C]-LY3537982 in Healthy ParticipantsCompletedNCT05901311Phase 1
- A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy ParticipantsCompletedNCT05894928Phase 1
- A Study of LY3532226 in Participants With Type 1 Diabetes MellitusCompletedNCT05887999Phase 1
- A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular DiseaseCompletedNCT05882045Phase 3
- A Study of the Effects of Itraconazole or Carbamazepine on LY3537982 in Healthy ParticipantsCompletedNCT05860933Phase 1
- An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid ArthritisCompletedNCT05848258Phase 2
- A Study of LY3819469 in Participants With Impaired and Normal Renal FunctionCompletedNCT05841277Phase 1
- A Study of the Effect of Food on LY3537982 in Healthy ParticipantsCompletedNCT05824858Phase 1
- A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid TumorsTerminatedNCT05821777Phase 1/2
- A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic SyndromeCompletedNCT05812781Phase 2
- A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskCompletedNCT05803421Phase 3
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative ColitisCompletedNCT05784246Phase 3
- A Study of LY3473329 in Participants With Impaired and Normal Renal FunctionCompletedNCT05778864Phase 1
- 18F-LY3950321-01 Biodistribution and Safety StudyCompletedNCT05775601Early Phase 1
- A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male ParticipantsCompletedNCT05757531Phase 1
- A Study of Carbon-14-Labelled [14C] LY3372689 in Healthy Male ParticipantsCompletedNCT05749848Phase 1
- A Study of LY3848575 in Healthy ParticipantsCompletedNCT05727072Phase 1
- VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)TerminatedNCT05715125Phase 2
- A Study of Continuous Blood Pressure Monitoring in Healthy ParticipantsCompletedNCT05692869Not applicable
- VTX958 for the Treatment of Moderately to Severely Active Crohn's DiseaseTerminatedNCT05688852Phase 2
- VTX958 Versus Placebo for the Treatment of Moderate to Severe PsoriasisTerminatedNCT05655299Phase 2
- A Study of LY3305677 in Participants With Obesity Or OverweightCompletedNCT05623839Phase 1
- A Relative Bioavailability Study of LY3209590 in Healthy ParticipantsCompletedNCT05615532Phase 1
- A Study of Effect of LY3556050 on Metformin in Healthy ParticipantsCompletedNCT05615467Phase 1
- A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal FunctionCompletedNCT05611957Phase 1
- A Study of LY3875383 in Healthy Participants and Participants With HypertriglyceridemiaTerminatedNCT05609825Phase 1
- Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)Active, not recruitingNCT05607810
- A Drug Interaction Study of LY3871801 in Healthy ParticipantsCompletedNCT05602675Phase 1
- A Study of LY3209590 in Chinese Participants With Type 2 Diabetes MellitusCompletedNCT05596747Phase 1
- A Study of LY3457263 in Obese ParticipantsCompletedNCT05582096Phase 1
- A Study of LY3526318 in Healthy Male Japanese ParticipantsWithdrawnNCT05580250Phase 1
- A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisActive, not recruitingNCT05559359Phase 3
- A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With ObesityActive, not recruitingNCT05556512Phase 3
- A Study of LY3437943 in Chinese Participants With Obesity Or OverweightCompletedNCT05548231Phase 1
- Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]Active, not recruitingNCT05536973Phase 2
- A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesCompletedNCT05536804Phase 2
- A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast CancerActive, not recruitingNCT05514054Phase 3
- A Study of LY3484356 in Chinese Participants With Advanced Breast CancerActive, not recruitingNCT05509790Phase 1
- A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)Active, not recruitingNCT05508789Phase 3
- A Study of LY3873862 in Healthy ParticipantsCompletedNCT05492201Phase 1
- A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)Active, not recruitingNCT05487599Phase 1/2
- A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)CompletedNCT05463731Phase 3
- A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese ParticipantsCompletedNCT05445232Phase 1
- A Study of LY3537021 in Healthy ParticipantsCompletedNCT05444569Phase 1
- A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese ParticipantsCompletedNCT05440136Phase 1